Business Standard

Mangalam Drugs and Organics standalone net profit declines 8.77% in the June 2017 quarter

Image

Capital Market

Sales decline 17.66% to Rs 55.14 crore

Net profit of Mangalam Drugs and Organics declined 8.77% to Rs 4.16 crore in the quarter ended June 2017 as against Rs 4.56 crore during the previous quarter ended June 2016. Sales declined 17.66% to Rs 55.14 crore in the quarter ended June 2017 as against Rs 66.97 crore during the previous quarter ended June 2016. ParticularsQuarter EndedJun. 2017Jun. 2016% Var.Sales55.1466.97 -18 OPM %17.9014.14 -PBDT7.417.19 3 PBT6.166.22 -1 NP4.164.56 -9

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Aug 14 2017 | 5:27 PM IST

Explore News